Galderma Group AG is a Swiss pharmaceutical company and the world's leading pure-play dermatology specialist, dedicated solely to advancing skin health across the full spectrum of dermatological treat... Galderma Group AG is a Swiss pharmaceutical company and the world's leading pure-play dermatology specialist, dedicated solely to advancing skin health across the full spectrum of dermatological treatments. Founded in 1981 as a joint venture between L'Oréal and Nestlé, the company became an independent entity in 2019 following a $10.2 billion acquisition by a consortium of institutional investors, and completed its initial public offering on the Swiss stock exchange in March 2024. Galderma operates through three strategic business units: Injectable Aesthetics, featuring flagship brands like Restylane, Azzalure, and Dysport for cosmetic procedures; Dermatological Skincare, offering over-the-counter products including Cetaphil, Differin, and Benzac for acne and general skin care; and Therapeutic Dermatology, providing prescription treatments for conditions such as atopic dermatitis, psoriasis, and prurigo nodularis. The company employs over 4,600 professionals across more than 100 countries and maintains six research and development centers alongside manufacturing facilities in France, Canada, Sweden, and Brazil. With a 40-year heritage of science-based innovation, Galderma serves consumers, patients, and healthcare professionals through its integrated strategy that combines cutting-edge product development with professional education and partnership programs.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Galderma Group is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Galderma Group is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Galderma Group's data?

Start your 30-day free trial to request a data review for Galderma Group.

Start Free Trial

Legal Center Contact Us